A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers
Clinical trial NCT04839042 · COMPLETED
Trial details
- NCT number
- NCT04839042
- Sponsor
- Moat Biotechnology Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-28
- Primary completion
- 2025-03-04
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.